Alcon, a prominent leader in eye care committed to enhancing vision, has recently unveiled the UNITY Vitreoretinal Cataract System (VCS) and the UNITY Cataract System (CS) in India.
Sanjivani Paranteral Limited's subsidiary, SPL Infusion Pvt. Ltd., has initiated commercial production at its newly established IV Fluid Infusion Plant located in Pune, Maharashtra, effective from 6th September 2025, following the acquisition of the
Cipla has officially launched HUENA (Methenamine Hippurate), India's first non-antibiotic UTI drug. This is especially timely, as UTIs are the second most common reason for antibiotic use in India, with the number of cases nearly doubling over the...
The Indian healthcare industry is increasingly recognizing artificial intelligence (AI) as a crucial strategic element, facilitating advanced treatments and promoting systemic efficiency throughout the sector.
Argo Biopharmaceutical, a biotechnology firm in the clinical stage that specializes in the development of next-generation siRNA therapeutics, has announced the establishment of an additional strategic partnership with Novartis concerning several
Poly Medicure, India's largest medical device company announced its acquisition of 90% of the PendraCare Group, including PendraCare Holdings and Wellinq Medical, from Wellinq Holdings B.V. The deal has an enterprise value of €18.3 million...
In an exclusive interview with Thiruamuthan, Correspondent at India Pharma Outlook, Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science, discusses how a dedicated formulation and technology centre addresses complex challenges i
The last ten years have seen unprecedented international momentum in GLP-1 obesity and diabetes treatment with injectable preparations changing the standard of care. The introduction of oral GLP-1 drugs is now a significant breakthrough, and it...
Granules India Limited, in collaboration with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, has officially opened the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical
Servier, an independent global pharmaceutical organization governed by a foundation, along with IDEAYA Biosciences, Inc., a prominent precision medicine oncology firm, have declared an exclusive licensing agreement aimed at making darovasertib
.jpg)
, CDSCO.jpg)